Review



s1648 cyclophosphamide mce  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    MedChemExpress s1648 cyclophosphamide mce
    S1648 Cyclophosphamide Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s1648 cyclophosphamide mce/product/MedChemExpress
    Average 95 stars, based on 57 article reviews
    s1648 cyclophosphamide mce - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    s1648 cyclophosphamide mce  (MedChemExpress)
    95
    MedChemExpress s1648 cyclophosphamide mce
    S1648 Cyclophosphamide Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s1648 cyclophosphamide mce/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    s1648 cyclophosphamide mce - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    cyclophosphamide  (MedChemExpress)
    95
    MedChemExpress cyclophosphamide
    Cyclophosphamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclophosphamide/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    cyclophosphamide - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    ctx model  (MedChemExpress)
    95
    MedChemExpress ctx model
    Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
    Ctx Model, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctx model/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    ctx model - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    mg mouse cyclophosphamide  (MedChemExpress)
    95
    MedChemExpress mg mouse cyclophosphamide
    Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
    Mg Mouse Cyclophosphamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mg mouse cyclophosphamide/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    mg mouse cyclophosphamide - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    non activated system  (MedChemExpress)
    95
    MedChemExpress non activated system
    Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the <t>CTX</t> group. NC: normal control, <t>CTX:</t> <t>cyclophosphamide,</t> AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
    Non Activated System, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non activated system/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    non activated system - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the CTX group. NC: normal control, CTX: cyclophosphamide, AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

    Journal: Frontiers in Pharmacology

    Article Title: Identify the therapeutic role and potential mechanism of α-cyperone in diminished ovarian reserve based on network pharmacology, molecular docking, Lip-MS and experimental validation

    doi: 10.3389/fphar.2025.1658536

    Figure Lengend Snippet: Effect of AC on target proteins. The mRNA expression levels of MAP2K1 (A) , GSK3B (B) , MAPK14 (C) , SRC (D) , AKT1 (E) , ESR2 (F) , ERBB2 (G) , CDH1 (H) , CYP19A1 (I) , ESR1 (J) , MAPK8 (K) , PARP1 (L) . AC treatment is able to reverse the abnormal gene expression of GSK3B, MAPK14, AKT1, ESR2, ERBB2, CYP19A1 and MAPK8 in the CTX group. NC: normal control, CTX: cyclophosphamide, AC: α-Cyperone, ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

    Article Snippet: Upon reaching approximately 80% confluency and displaying favorable condition, the cells were divided into three groups (n = 6 wells per group, three independent passages on different days): The normal control (NC group): complete medium only; CTX model (CTX group): 10 μg/mL cyclophosphamide (Sigma, C3250000) dissolved in serum-free DMEM; α-Cyperone (AC group): pre-treated with varying concentrations α-Cyperone (MedChemExpress, HY-N0710) for 6 h, followed by 10 μg/mL CTX without wash-out.

    Techniques: Expressing, Gene Expression, Control